Sign in
4

Changes in Ownership

AYTU BIOPHARMA, INC Filed Acc 0001437749-25-030642

Chief Executive Officer acquired 53,946 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Disbrow Joshua R. · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2025-10-03 Grant or award : show line 1 in the form +31,446 184,703 D
2025-10-03 Grant or award : show line 2 in the form +22,500 207,203 D
Loading xslF345X05/rdgdoc.xml…